Physician profile
Michael Meyer
NPI 1588624662
$20,353.92
in general payments reported to CMS, 2019-2025
19 companies · $809 in 2025
The $809 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $176 · 2021: $184 · 2022: $919 · 2023: $3,512 · 2024: $296 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,787 · Travel and Lodging: $1,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,787.02 |
| Travel and Lodging | $1,829.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,981.78 | 2019-2023 | Da Vinci Surgical System |
| Abbott Laboratories | $3,122.84 | 2020-2024 | Mitraclip, 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $670.77 | 2022-2023 | Impella |
| Microvention, INC. | $521.93 | 2024-2025 | Web Aneurysm Embolization System, Stent, Balloon Catheter |
| Edwards Lifesciences Corporation | $249.02 | 2022-2025 | Pascal, Mitris Resilia Mitral Valve |
| Stryker Corporation | $216.15 | 2024-2025 | Evolve, Surpass Evolve, Target |
| Medtronic, INC. | $159.03 | 2021 | |
| Atricure, INC. | $117.76 | 2019-2024 | |
| Ethicon US, LLC | $62.95 | 2022-2025 | Ethicon, Vistaseal |
| Depuy Synthes Sales INC. | $48.11 | 2020 | |
| Angiodynamics, INC. | $46.10 | 2019 | |
| Portola Pharmaceuticals, LLC | $34.91 | 2019 | |
| Medtronic Vascular, INC. | $30.00 | 2019 | |
| Lsi Solutions INC | $28.61 | 2025 | Ti-Knot, Cor-Knot |
| Davol INC. | $20.98 | 2023 | Progel Applicator Spray Tips |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $16.54 | 2025 | Penumbra System |
| Pulmonx Corporation | $13.74 | 2019 | |
| Hemosonics LLC | $12.70 | 2023 | Quantra Qplus System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.